Future mRNA Vaccine Applications Highlighted

The New York Post recently published an article discussing future applications of mRNA, including vaccinations against tuberculosis, malaria, high cholesterol, HIV, as well as cancer treatment, enzyme replacement therapies, immunotherapies, and more. The article mentions Penn’s Dr. Katalin Kariko, co-inventor of the mRNA technology used in the covid-19 vaccine, who explains how mRNA vaccines serve as the “middleman between information and action” for prophylactic and therapeutic vaccine applications of the technology. Rather than injecting part of the virus into the patient as is more typical with a traditional vaccine approach, mRNA vaccines provide recipient cells with instructions on how to make necessary proteins or antibodies to help the patient immune system recognize and fight off infectious agents. 

Learn more about the future of mRNA by reading the article here

Skip to content